BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4760035)

  • 1. The effect of ethinyloestradiol on calcium and phosphorus metabolism of post-menopausal women with primary hyperparathyroidism.
    Gallagher JC; Wilkinson R
    Clin Sci Mol Med; 1973 Dec; 45(6):785-802. PubMed ID: 4760035
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of ethinyl oestradiol on calcium and phosphorus metabolism in osteoporosis.
    Young MM; Jasani C; Smith DA; Nordin BE
    Clin Sci; 1968 Jun; 34(3):411-7. PubMed ID: 5666871
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women.
    Gallagher JC; Nordin BE
    Lancet; 1972 Mar; 1(7749):503-7. PubMed ID: 4110019
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women.
    Selby PL; Peacock M
    N Engl J Med; 1986 Jun; 314(23):1481-5. PubMed ID: 3754618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ethinyl oestradiol on calcium and bone metabolism in peri- and postmenopausal women.
    Marshall RW; Selby PL; Chilvers DC; Hodgkinson A
    Horm Metab Res; 1984 Feb; 16(2):97-9. PubMed ID: 6706290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones.
    Selby PL; Peacock M; Barkworth SA; Brown WB; Taylor GA
    Clin Sci (Lond); 1985 Sep; 69(3):265-71. PubMed ID: 3933891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevention and management of post-menopausal osteoporosis.
    Marshall DH; Horsman A; Nordin BE
    Acta Obstet Gynecol Scand Suppl; 1977; 65():49-56. PubMed ID: 269626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.
    Broulik PD; Stĕpán J; Pacovský V
    Exp Clin Endocrinol; 1984 May; 83(3):315-9. PubMed ID: 6540700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A; Baker RK; Wallach S
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
    Horowitz M; Need AG; Philcox JC; Nordin BE
    Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary hydroxyproline concentration in primary hyperparathyroidism with and without renal stones.
    Sommer-Tsilenis E
    Eur Urol; 1977; 3(4):231-6. PubMed ID: 913450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
    Marshall DH; Gallagher JC; Guha P; Hanes F; Oldfield W; Nordin BE
    Calcif Tissue Res; 1977 May; 22 Suppl():78-84. PubMed ID: 334349
    [No Abstract]   [Full Text] [Related]  

  • 13. Conjugated estrogens in the treatment of postmenopausal women with hyperparathyroidism.
    Marcus R; Madvig P; Crim M; Pont A; Kosek J
    Ann Intern Med; 1984 May; 100(5):633-40. PubMed ID: 6324624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical effects of a calcium supplement in postmenopausal women with primary hyperparathyroidism.
    Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
    Horm Metab Res; 1994 Jan; 26(1):39-42. PubMed ID: 8150422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute changes in calcium homeostasis during treatment of primary hyperparathyroidism with risedronate.
    Reasner CA; Stone MD; Hosking DJ; Ballah A; Mundy GR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1067-71. PubMed ID: 8408454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPINAL OSTEOPOROSIS AND THE MENOPAUSE.
    JASANI C; NORDIN BE; SMITH DA; SWANSON I
    Proc R Soc Med; 1965 Jun; 58(6):441-4. PubMed ID: 14291272
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of oestrogen and progestogen therapy on calcium metabolism in post-menopausal women.
    Gallagher JC; Nordin EC
    Front Horm Res; 1975; 3():150-76. PubMed ID: 1234561
    [No Abstract]   [Full Text] [Related]  

  • 19. The relation between bone loss and calcium balance in women.
    Horsman A; Marshall DH; Nordin BE; Crilly RG; Simpson M
    Clin Sci (Lond); 1980 Aug; 59(2):137-42. PubMed ID: 7408419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chlorothiazide on bone-related biochemical variables in normal post-menopausal women.
    Peh CA; Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
    J Am Geriatr Soc; 1993 May; 41(5):513-6. PubMed ID: 8486884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.